Latest news

Update on funding of further development

Posted on Oct 27, 2016

Oslo, October 27, 2016 – Reference is made to PCI Biotech Holding ASA’s (“PCI Biotech” or the “Company”) stock exchange announcement on 30 August 2016 in relation to the Q2 2016 report and its evaluation of the Company’s strategic options, capital need and financing alternatives. The Board of Directors has, in understanding with the largest […]

Results from the bile duct cancer study will be presented as late-breaking news at United European Gastroenterology Week

Posted on Oct 17, 2016

Oslo, October 17, 2016 – PCI Biotech today announced that an abstract with results from the phase I bile duct cancer study has been selected for oral presentation as late-breaking news at the United European Gastroenterology (UEG) Week. The results will be presented by Dr. Alexander Dechêne, University Hospital Essen, Germany, who is one of […]

PCI Biotech to present poster at the Second International Cancer Immunotherapy Conference

Posted on Sep 23, 2016

Oslo, September 23, 2016 – PCI Biotech will present a poster at CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 2016. This year’s event is called “Translating Science into Survival” and is held at the Sheraton Times Square Hotel and the New York Hilton Midtown in New York City, September 25-28, 2016. The company will be represented by […]